We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTEQ:NASDAQT. Rowe Price Technology ETF Analysis

Data as of 2026-05-06 - not real-time

$40.12

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TTEQ is trading at its 52‑week high of $40.12, just above the 20‑day SMA (36.23) and the 50‑day SMA (33.30), confirming a strong bullish momentum. The RSI of 79.95 signals an overbought condition, while the MACD remains bullish (line above signal, positive histogram). Volume has been decreasing, suggesting a potential short‑term softening despite the overall bullish trend. The fund’s YTD return of 15.55% and an “Extreme Greed” sentiment (Fear & Greed Index 90.52) underscore strong recent investor enthusiasm, but the high beta (1.64) and 30‑day volatility (31.3%) highlight heightened sensitivity to market swings. No material news specific to TTEQ was identified, so the outlook relies solely on these technical and fund metrics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price at resistance level
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD alignment
  • Strong YTD performance
  • Technology sector tailwinds (AI, cloud)

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term growth prospects for technology
  • Active management seeking tech winners
  • Diversification benefit within a tech‑focused portfolio

Key Metrics & Analysis

Fund Metrics

Expense Ratio0.63%
AUM$197.6M
Inception Date2024-10-23
Avg Daily Volume42,120
Premium/Discount0.00%
Tracking Error0.00%

Technical Analysis

TrendBullish
RSI80.0
Support$32.31
Resistance$40.12
MA 20$36.23
MA 50$33.30
MA 200$32.44
MACDBullish
VolumeDecreasing
Fear & Greed Index90.52

Risk Assessment

Beta1.64
Volatility31.32%
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.